Protein kinase C and other diacylglycerol effectors in cancer
The DOI matches its Crossref record; 191 of the 191 references it cites were found in a registry or an index.
Abstract
Almost three decades after the discovery of protein kinase C (PKC), we still have only a partial understanding of how this family of serine/threonine kinases is involved in tumour promotion. PKC isozymes - effectors of diacylglycerol (DAG) and the main targets of phorbol-ester tumour promoters - have important roles in cell-cycle regulation, cellular survival, malignant transformation and apoptosis. How do PKC isozymes regulate these diverse cellular processes and what are their contributions to carcinogenesis? Moreover, what is the contribution of all phorbol-ester effectors, which include PKCs and small G-protein regulators? We now face the challenge of dissecting the relative contribution of each DAG signal to cancer progression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IP3 triggers calcium release from intracellular stores, while DAG activates protein kinase C (PKC) and other effector proteins, ultimately influencing microglial processes such as migration, phagocytosis, cytokine secretion, and metabolic responses. 13 , 16 , 17”
From Alzheimer's disease–associated PLCG2 variants alter microglial state and function in human induced pluripotent stem cell–derived microglia‐like cells (2025) · cites this paper as [17]
In the citing paper
“and DAG leading to activation of protein kinase C (PKC) isozymes, the NLRP3 inflammasome [31, 34], as well as other proteins [77].”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [77]
In the citing paper
“Conversely, phorbol esters, the naturally occurring activating ligands of PKC, showed tumor‐promoting functions, suggesting that PKC could be an oncogene [111, 120, 121].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [121]
Citations
Cites
Castagna, M., Takai, Y., Kaibuchi, K., Sano, K., Kikkawa, U., & Nishizuka, Y. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34459-4 · Cited by 4,725 · cited 3×
“Chimaerins (α2, β2) Rac-GAPC1SH2 PKDs (1, 2, 3) C1A C1B Protein kinasePH nPKCs (δ, ε, η, θ) Protein kinaseC2 C1A C1B ApcMin/+mouse A mouse strain harbouring a nonsense mutation at codon 850 in one allele of the Apc (adenomatous polyposis coli) gene.”
BackgroundKishimoto, A., Takai, Y., Mori, T., Kikkawa, U., & Nishizuka, Y. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85886-6 · Cited by 1,303
Protein kinase C as a possible receptor protein of tumor‐promoting phorbol esters
Kikkawa, U., Takai, Y., Tanaka, Y., Miyake, R., & Nishizuka, Y. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44245-1 · Cited by 881 · cited 2×
“Chimaerins (α2, β2) Rac-GAPC1SH2 PKDs (1, 2, 3) C1A C1B Protein kinasePH nPKCs (δ, ε, η, θ) Protein kinaseC2 C1A C1B ApcMin/+mouse A mouse strain harbouring a nonsense mutation at codon 850 in one allele of the Apc (adenomatous polyposis coli) gene.”
Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm
NEWTON, A. C. (2003) · Biochemical Journal · doi:10.1042/bj20021626 · Cited by 798
Takai, Y., Kishimoto, A., Kikkawa, U., Mori, T., & Nishizuka, Y. (1979) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(79)91197-5 · Cited by 731 · cited 1×
“Nishizuka and colleagues found that PKC could be activated by the lipid diacylglycerol (DAG) in the presence of phosphatidylserine as a cofacto”
BackgroundRasGRP, a Ras Guanyl Nucleotide- Releasing Protein with Calcium- and Diacylglycerol-Binding Motifs
Ebinu, J. O., Bottorff, D. A., Chan, E. Y. W., Stang, S. L., Dunn, R. J., & Stone, J. C. (1998) · Science · doi:10.1126/science.280.5366.1082 · Cited by 689
Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells.
Emoto, Y., Manome, Y., Meinhardt, G., Kisaki, H., Kharbanda, S., Robertson, M., Ghayur, T., Wong, W. W., Kamen, R., & Weichselbaum, R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00305.x · Cited by 670
Multiple pathways control protein kinase C phosphorylation
Parekh, D. B., Ziegler, W., & Parker, P. J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.4.496 · Cited by 601 · cited 1×
“The mechanisms involved in PKC activation have been extensively studie”
BackgroundTakahashi, T., Ueno, H., & Shibuya, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202527 · Cited by 571
Xia, P., Aiello, L. P., Ishii, H., Jiang, Z. Y., Park, D. J., Robinson, G. S., Takagi, H., Newsome, W. P., Jirousek, M. R., & King, G. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119006 · Cited by 566 · cited 1×
“Several PKC isoforms, including PKCα, β and e, are activated in response to VEGF receptor activation, and PKC has been implicated as an important mediator of VEGF-induced proliferation of endothelial cell”
Background
Research works printed but not linked: 1
- Wu, E. X. et al. PKCβ: a rational therapeutic target in diffuse large B-cell lymphoma. Blood 100, 202A–202A (2002).
Cited by
The multifaceted roles of fatty acid synthesis in cancer
Röhrig, F., & Schulze, A. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.89 · Cited by 1,651
Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis
Pinton, P., Giorgi, C., Siviero, R., Zecchini, E., & Rizzuto, R. (2008) · Oncogene · doi:10.1038/onc.2008.308 · Cited by 1,157
“Oncogene Protein kinases C can have a dual function in apoptosis, that is, the activation of specific PKC isoforms may protect or induce cell death, often in a cell-type-specific manner (Lavin et al., 1996; Liu et al., 2002; Griner and Kazanietz, 2007).”
BackgroundKang, Q., & Yang, C. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101799 · Cited by 1,066
“The family of PKC contains 12 isoforms, in which PKC-α, -β, -δ, and -ε has been reported to be activated during the development of DR [57,58].”
BackgroundElectrochemical Methods for the Analysis of Clinically Relevant Biomolecules
Labib, M., Sargent, E. H., & Kelley, S. O. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00220 · Cited by 976
Structural Basis of Protein Kinase C Isoform Function
Steinberg, S. F. (2008) · Physiological Reviews · doi:10.1152/physrev.00034.2007 · Cited by 872
“General reviews that examine the physiological consequences of PKC isoform activation in individual tissues have appeared elsewhere (21, 71, 119, 137, 139, 201, 230); these topics are beyond the scope of this review and will not be covered.”
BackgroundHydrogen Sulfide Mediates Cardioprotection Through Nrf2 Signaling
Calvert, J. W., Jha, S., Gundewar, S., Elrod, J. W., Ramachandran, A., Pattillo, C. B., Kevil, C. G., & Lefer, D. J. (2009) · Circulation Research · doi:10.1161/circresaha.109.199919 · Cited by 723
Multitargeting by curcumin as revealed by molecular interaction studies
Gupta, S. C., Prasad, S., Kim, J. H., Patchva, S., Webb, L. J., Priyadarsini, I. K., & Aggarwal, B. B. (2011) · Natural Product Reports · doi:10.1039/c1np00051a · Cited by 669
Key Characteristics of Carcinogens as a Basis for Organizing Data on Mechanisms of Carcinogenesis
Smith, M. T., Guyton, K. Z., Gibbons, C. F., Fritz, J. M., Portier, C. J., Rusyn, I., DeMarini, D. M., Caldwell, J. C., Kavlock, R. J., Lambert, P. F., et al. (2016) · Environmental Health Perspectives · doi:10.1289/ehp.1509912 · Cited by 650
“A component common to all three scenarios is the evasion of apoptosis or other terminal programming, including autophagy, in at least a proportion of the cell population (Ryter et al. 2014).”
BackgroundEssential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling
Ikenoue, T., Inoki, K., Yang, Q., Zhou, X., & Guan, K. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.119 · Cited by 610
“Protein kinase C (PKC) is one of the most extensively studied kinase family and has been implicated in cell proliferation, differentiation, apoptosis, tumour promotion and neuronal activity (Griner and Kazanietz, 2007).”
BackgroundHeger, M., van Golen, R. F., Broekgaarden, M., & Michel, M. C. (2014) · Pharmacological Reviews · doi:10.1124/pr.110.004044 · Cited by 576
“Over the last years, however, it has become apparent that each isoform is entangled in a number of different, often opposing signaling pathways (Griner and Kazanietz, 2007).”
BackgroundProtein kinase C, an elusive therapeutic target?
Mochly-Rosen, D., Das, K., & Grimes, K. V. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3871 · Cited by 563
Feng, X., Degese, M. S., Iglesias-Bartolome, R., Vaque, J. P., Molinolo, A. A., Rodrigues, M., Zaidi, M. R., Ksander, B. R., Merlino, G., Sodhi, A., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.016 · Cited by 563
“IP3 raises cytoplasmic Ca 2+ levels, which stimulates multiple calcium-regulated pathways and, together with DAG, activates classic protein kinase C isoforms (Griner and Kazanietz, 2007).”
BackgroundThe Keap1-Nrf2 System: A Mediator between Oxidative Stress and Aging
Yu, C., & Xiao, J.-H. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6635460 · Cited by 537
“PKC is a family of serine/threonine kinases that regulates cell proliferation, survival, apoptosis, and migration [128].”
BackgroundProtein kinase C: poised to signal
Newton, A. C. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00477.2009 · Cited by 512
Caspases and Kinases in a Death Grip
Kurokawa, M., & Kornbluth, S. (2009) · Cell · doi:10.1016/j.cell.2009.08.021 · Cited by 474
“, 2002), where it phosphorylates several proteins, including lamin B, DNA-PK, p53, p73β, and Rad9 (Griner and Kazanietz, 2007) (Figure 3).”
A small molecule that directs differentiation of human ESCs into the pancreatic lineage
Chen, S., Borowiak, M., Fox, J. L., Maehr, R., Osafune, K., Davidow, L., Lam, K., Peng, L. F., Schreiber, S. L., Rubin, L. L., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.154 · Cited by 478
“PKC is a family of serine/threonine kinases that regulates a very diverse set of cellular processes, including differentiation, proliferation, apoptosis, cell migration and cell surviva”
A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages
Lu, H., Clauser, K. R., Tam, W. L., Fröse, J., Ye, X., Eaton, E. N., Reinhardt, F., Donnenberg, V. S., Bhargava, R., Carr, S. A., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3041 · Cited by 459
Mitogenic signaling pathways induced by G protein‐coupled receptors
Rozengurt, E. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21246 · Cited by 460
“…EGFR transactivation is mediated by the release of precursor forms of the EGFR ligands HB-EGF, TGF-a, and/or amphiregulin (Prenzel et al., 1999; Gschwind et al., 2003; Santiskulvong and Rozengurt, 2003; Shah et al., 2004; Schafer et al., 2004a) generated by activation of metalloproteinases of…”
BackgroundMembranes: A meeting point for lipids, proteins and therapies
Escribá, P. V., González‐Ros, J. M., Goñi, F. M., Kinnunen, P. K. J., Vigh, L., Sánchez‐Magraner, L., Fernández, A. M., Busquets, X., Horváth, I., & Barceló‐Coblijn, G. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00281.x · Cited by 454
“Since its identification in the bovine cerebellum [239], membrane-associated PKC isozymes have been shown to be fundamental signal transduction molecules, involved in a huge variety of events including cell-cycle regulation, cellular survival, malignant transformation and apoptosis [240].”
BackgroundDiacylglycerol kinases: at the hub of cell signalling
Mérida, I., Ávila-Flores, A., & Merino, E. (2008) · Biochemical Journal · doi:10.1042/bj20071040 · Cited by 427
Protein kinase C controls lysosome biogenesis independently of mTORC1
Li, Y., Xu, M., Ding, X., Yan, C., Song, Z., Chen, L., Huang, X., Wang, X., Jian, Y., Tang, G., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3407 · Cited by 353
“HEP14-biotin (∼0.8 µg) immobilized on streptavidin-agarose beads (20 µl) was then incubated in Hepes buffer with MBP, MBP-PKCα-C1 or MBP-PKCδ-C1 (3 µg of each) with different © Macmillan Publishers Limited .”
MethodInfluentialProtein kinase C: perfectly balanced
Newton, A. C. (2018) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2018.1442408 · Cited by 335
Cancer-Associated Protein Kinase C Mutations Reveal Kinase’s Role as Tumor Suppressor
Antal, C. E., Hudson, A. M., Kang, E., Zanca, C., Wirth, C., Stephenson, N. L., Trotter, E. W., Gallegos, L. L., Miller, C. J., Furnari, F. B., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.001 · Cited by 330
“This led to the dogma that activation of PKC by phorbol esters promotes carcinogen-induced tumorigenesis (Griner and Kazanietz, 2007), yet targeting PKC in cancer has been unsuccessful.”
Protein Kinase C α Is a Central Signaling Node and Therapeutic Target for Breast Cancer Stem Cells
Tam, W. L., Lu, H., Buikhuisen, J., Soh, B. S., Lim, E., Reinhardt, F., Wu, Z. J., Krall, J. A., Bierie, B., Guo, W., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.005 · Cited by 321
“While PKCα has been implicated in promoting cancer progression (Griner and Kazanietz, 2007; Lonne et al., 2010), its connection to cell-state transitions and CSCs has been unclear.”
Role of Phospholipids in Endocytosis, Phagocytosis, and Macropinocytosis
Bohdanowicz, M., & Grinstein, S. (2013) · Physiological Reviews · doi:10.1152/physrev.00002.2012 · Cited by 311
Tumor microenvironment signaling and therapeutics in cancer progression
Goenka, A., Khan, F., Verma, B., Sinha, P., Dmello, C. C., Jogalekar, M. P., Gangadaran, P., & Ahn, B. (2023) · Cancer Communications · doi:10.1002/cac2.12416 · Cited by 323
“Conversely, phorbol esters, the naturally occurring activating ligands of PKC, showed tumor-promoting functions, suggesting that PKC could be an oncogene [111, 120, 121].”
BackgroundRedox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy
Marengo, B., Nitti, M., Furfaro, A. L., Colla, R., Ciucis, C. D., Marinari, U. M., Pronzato, M. A., Traverso, N., & Domenicotti, C. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/6235641 · Cited by 319
“Specifically, PKCδmay be overexpressed in colon cancers and downregulated in malignant gliomas, bladder carcinomas, and endometrial tumors [154].”
BackgroundRegulation of sphingosine kinase and sphingolipid signaling
Pitson, S. M. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.08.001 · Cited by 307
Novel insights into G protein and G protein-coupled receptor signaling in cancer
O’Hayre, M., Degese, M. S., & Gutkind, J. S. (2014) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2014.01.005 · Cited by 296
Protein kinase C and cancer: what we know and what we do not
Garg, R., Benedetti, L. G., Abera, M. B., Wang, H., Abba, M., & Kazanietz, M. G. (2014) · Oncogene · doi:10.1038/onc.2013.524 · Cited by 303
“aPKCs display unique regulatory properties: they are unable to bind DAG or calcium and rather depend on proteinprotein interactions and phosphorylation for their activation [3] (Fig.”
BackgroundInfluentialSelf-citationPotential of Jatropha curcas as a source of renewable oil and animal feed
King, A. J., He, W., Cuevas, J. A., Freudenberger, M., Ramiaramanana, D., & Graham, I. A. (2009) · Journal of Experimental Botany · doi:10.1093/jxb/erp025 · Cited by 291
Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab
Brand, T. M., Iida, M., & Wheeler, D. L. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.9.15050 · Cited by 273
Regulation of translocator protein 18kDa (TSPO) expression in health and disease states☆
Batarseh, A., & Papadopoulos, V. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.06.013 · Cited by 270
“[PubMed: 19386723] Fields AP, Gustafson WC. Protein kinase C in disease: cancer.”
BackgroundInfluentialProtein Kinases and Phosphatases in the Control of Cell Fate
Bononi, A., Agnoletto, C., De Marchi, E., Marchi, S., Patergnani, S., Bonora, M., Giorgi, C., Missiroli, S., Poletti, F., Rimessi, A., et al. (2011) · Enzyme Research · doi:10.4061/2011/329098 · Cited by 285
“activity [28].”
Cancer stem cells and radioresistance
Rycaj, K., & Tang, D. G. (2014) · International Journal of Radiation Biology · doi:10.3109/09553002.2014.892227 · Cited by 254
“Members of the protein kinase C (PKC) family of serine/threonine kinases are key components of signal transduction pathways that regulate proliferation, cell survival and malignant transformation (Parekh et al. 2000, Steinberg 2004, Griner and Kazanietz 2007).”
BackgroundUveal melanoma: Towards a molecular understanding
Smit, K. N., Jager, M. J., de Klein, A., & Kiliҫ, E. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.100800 · Cited by 264
“Activated PLCB4 causes a rise in cytoplasmic Ca, thereby activating several calcium-regulated pathways (Griner and Kazanietz, 2007).”
BackgroundProtein kinase C isoforms: Multi-functional regulators of cell life and death
Reyland, M. (2009) · Frontiers in Bioscience · doi:10.2741/3385 · Cited by 266
Finicle, B. T., Jayashankar, V., & Edinger, A. L. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0048-x · Cited by 228
Feng, X., Arang, N., Rigiracciolo, D. C., Lee, J. S., Yeerna, H., Wang, Z., Lubrano, S., Kishore, A., Pachter, J. A., König, G. M., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.01.009 · Cited by 237
“The activation of these second-messenger systems and their direct targets, including ion channels and kinases such as PKC, calcium/calmodulin-dependent protein kinases, and mitogen-activated protein kinase (MAPK), are responsible for most of the rapid physiological responses elicited by GPCRs (Griner and Kazanietz, 20…”
BackgroundRuiz-Torres, V., Encinar, J., Herranz-López, M., Pérez-Sánchez, A., Galiano, V., Barrajón-Catalán, E., & Micol, V. (2017) · Molecules · doi:10.3390/molecules22071037 · Cited by 229
Phosphatidic acid in membrane rearrangements
Zhukovsky, M. A., Filograna, A., Luini, A., Corda, D., & Valente, C. (2019) · FEBS Letters · doi:10.1002/1873-3468.13563 · Cited by 212
Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations
Chen, X., Wu, Q., Tan, L., Porter, D., Jager, M. J., Emery, C., & Bastian, B. C. (2014) · Oncogene · doi:10.1038/onc.2013.418 · Cited by 208
The Phosphatase PHLPP Controls the Cellular Levels of Protein Kinase C
Gao, T., Brognard, J., & Newton, A. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707319200 · Cited by 206
Aziz, M. H., Dreckschmidt, N. E., & Verma, A. K. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2494 · Cited by 208
“PKCε is a member of the novel PKC subfamily (29-33).”
BackgroundEffects of Intestinal Microbial–Elaborated Butyrate on Oncogenic Signaling Pathways
Chen, J., Zhao, K.-N., & Vitetta, L. (2019) · Nutrients · doi:10.3390/nu11051026 · Cited by 198
Desai, N. R., Kesari, K. K., & Agarwal, A. (2009) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-7-114 · Cited by 198
Metabolic control of oocyte development: linking maternal nutrition and reproductive outcomes
Gu, L., Liu, H., Gu, X., Boots, C., Moley, K. H., & Wang, Q. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1739-4 · Cited by 204
Koh, W., Mahan, R. D., & Davis, G. E. (2008) · Journal of Cell Science · doi:10.1242/jcs.020693 · Cited by 195
“…and PKCε have been shown to be involved in angiogenesis, EC permeability, tumor metastasis and inflammation, whereas PKCζ is a key member of the Cdc42-mediated polarity complex (Cheng et al., 2001; Griner and Kazanietz, 2007; Macara, 2004b; Orr et al., 2006; Saha et al., 2003; Taylor et al., 2006).”
BackgroundMEK inhibitor resistance mechanisms and recent developments in combination trials
Kun, E., Tsang, Y. T. M., Ng, C. W., Gershenson, D. M., & Wong, K. K. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.102137 · Cited by 184
Protein kinase C pharmacology: refining the toolbox
Wu-zhang, A. X., & Newton, A. C. (2013) · Biochemical Journal · doi:10.1042/bj20130220 · Cited by 195
RhoA and ROCK mediate histamine-induced vascular leakage and anaphylactic shock
Mikelis, C. M., Simaan, M., Ando, K., Fukuhara, S., Sakurai, A., Amornphimoltham, P., Masedunskas, A., Weigert, R., Chavakis, T., Adams, R. H., et al. (2015) · Nature Communications · doi:10.1038/ncomms7725 · Cited by 192
EGFR Signals to mTOR Through PKC and Independently of Akt in Glioma
Fan, Q.-W., Cheng, C., Knight, Z. A., Haas-Kogan, D., Stokoe, D., James, C. D., McCormick, F., Shokat, K. M., & Weiss, W. A. (2009) · Science Signaling · doi:10.1126/scisignal.2000014 · Cited by 186
PHLiPPing the switch on Akt and protein kinase C signaling
Brognard, J., & Newton, A. C. (2008) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2008.04.001 · Cited by 183
Essential Role of TRPC6 Channels in G2/M Phase Transition and Development of Human Glioma
Ding, X., He, Z., Zhou, K., Cheng, J., Yao, H., Lu, D., Cai, R., Jin, Y., Dong, B., Xu, Y., et al. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq217 · Cited by 179
Lipid Metabolic Reprogramming in Hepatocellular Carcinoma
Nakagawa, H., Hayata, Y., Kawamura, S., Yamada, T., Fujiwara, N., & Koike, K. (2018) · Cancers · doi:10.3390/cancers10110447 · Cited by 174
Lu, X., Yu, L., Zhang, Z., Ren, X., Smaill, J. B., & Ding, K. (2018) · Medicinal Research Reviews · doi:10.1002/med.21488 · Cited by 173
Wu, W.-S., Wu, J.-R., & Hu, C.-T. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9112-4 · Cited by 171
“tal organization, migration, and apoptosis [78].”
RasGRP3 Mediates MAPK Pathway Activation in GNAQ Mutant Uveal Melanoma
Chen, X., Wu, Q., Depeille, P., Chen, P., Thornton, S., Kalirai, H., Coupland, S. E., Roose, J. P., & Bastian, B. C. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.04.002 · Cited by 171
“The PKC family consists of at least ten serine/threonine kinases, which are subdivided into classic, novel, and atypical isoforms (Griner and Kazanietz, 2007).”
BackgroundVaqué, J. P., Dorsam, R. T., Feng, X., Iglesias-Bartolome, R., Forsthoefel, D. J., Chen, Q., Debant, A., Seeger, M. A., Ksander, B. R., Teramoto, H., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.10.018 · Cited by 162
“IP3 raises cytoplasmic Ca2+ levels, which stimulates multiple calcium-regulated pathways and together with DAG, activates classic PKC isoforms (Griner and Kazanietz, 2007).”
A Diacylglycerol-Dependent Signaling Pathway Contributes to Regulation of Antibacterial Autophagy
Shahnazari, S., Yen, W.-L., Birmingham, C. L., Shiu, J., Namolovan, A., Zheng, Y. T., Nakayama, K., Klionsky, D. J., & Brumell, J. H. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.07.002 · Cited by 153
“Therefore, the generation of DAG on SCVs and subsequent autophagy of S. Typhimurium requires the action of both PAP and PLD. Classical and novel PKC isoforms contain DAG-binding C1 domains, and DAG binding has an impact upon their function (Griner and Kazanietz, 2007; Kazanietz, 2000).”
BackgroundTotal Synthesis of Bryostatin 1
Keck, G. E., Poudel, Y. B., Cummins, T. J., Rudra, A., & Covel, J. A. (2010) · Journal of the American Chemical Society · doi:10.1021/ja110198y · Cited by 162
SRF Co-factors Control the Balance between Cell Proliferation and Contractility
Gualdrini, F., Esnault, C., Horswell, S., Stewart, A., Matthews, N., & Treisman, R. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.10.016 · Cited by 161
“To activate TCF-SRF signaling in MEFs, we used the phorbol ester TPA, which activates ERK via protein kinase C (PKC) and RasGRP1 (Griner and Kazanietz, 2007).”
MethodSphingomyelin Synthase 2 Deficiency Attenuates NFκB Activation
Hailemariam, T. K., Huan, C., Liu, J., Li, Z., Roman, C., Kalbfeisch, M., Bui, H. H., Peake, D. A., Kuo, M.-S., Cao, G., et al. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.168682 · Cited by 153
Lipid activation of protein kinases
Newton, A. C. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800064-jlr200 · Cited by 157
“The activity of these kinases is exquisitely controlled, and deregulation of this activity results in pathological states, most notably cancer (37, 38 ).”
BackgroundProtein kinase C family: On the crossroads of cell signaling in skin and tumor epithelium
Breitkreutz, D., Braiman, L., Schneider‐Daum, N., Denning, M. F., & Tennenbaum, T. (2007) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-007-0280-3 · Cited by 169
“Like for activation this may involve other internal proteases like caspases (Akkaraju and Basu 2000; Datta et al. 1997; Denning et al. 1998) or turnover via the ubiquitinylation/proteasome pathway (Griner and Kazanietz 2007).”
BackgroundMethodInfluentialmiR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53
Navarro, F., Gutman, D., Meire, E., Cáceres, M., Rigoutsos, I., Bentwich, Z., & Lieberman, J. (2009) · Blood · doi:10.1182/blood-2009-02-205062 · Cited by 152
Cho, E., Choi, S.-Y., Kim, H., Choi, E.-J., Lee, E., Park, P. J., Ko, J., Kim, K. P., & Baek, H. S. (2021) · Cells · doi:10.3390/cells10030486 · Cited by 154
G Protein‐Coupled receptors and heterotrimeric G proteins as cancer drivers
Arang, N., & Gutkind, J. S. (2020) · FEBS Letters · doi:10.1002/1873-3468.14017 · Cited by 157
The Life and Death of Protein Kinase C
Gould, C., & Newton, A. (2008) · Current Drug Targets · doi:10.2174/138945008785132411 · Cited by 146
Wen, Y., Alshikho, M. J., & Herbert, M. R. (2016) · PLOS ONE · doi:10.1371/journal.pone.0153329 · Cited by 150
“PKC and Ras-MAPK/ERK signaling are both known to be associated with cancer [18,47] and involved in regulation of metabolism [23,48].”
BackgroundWang, S., Liu, S., Sun, H., Huang, T., Chan, C.-H., Yang, C., Yeh, H., Huang, Y., Chou, W., Lin, Y., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu218 · Cited by 156
B-cell deficiency and severe autoimmunity caused by deficiency of protein kinase C δ
Salzer, E., Santos-Valente, E., Klaver, S., Ban, S. A., Emminger, W., Serwas, N. K., Garncarz, W., Müllauer, L., Kain, R., Boztug, H., et al. (2013) · Blood · doi:10.1182/blood-2012-10-460741 · Cited by 149
Molecular Mechanisms of Mouse Skin Tumor Promotion
Rundhaug, J. E., & Fischer, S. M. (2010) · Cancers · doi:10.3390/cancers2020436 · Cited by 133
“Upon displacement of the pseudosubstrate domain by ligands such as DAG, the enzyme becomes catalytically active [22,23].”
BackgroundInfluentialPan, M., Chiou, Y.-S., Chen, W. J., Wang, J., Badmaev, V., & Ho, C. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp121 · Cited by 142
“Among these stimulators, TPA is a well-known substitute for DAG as a high affinity ligand for conventional protein kinase C (cPKC) and novel PKC isoforms [19].”
BackgroundProtein kinase Cε: an oncogene and emerging tumor biomarker
Gorin, M. A., & Pan, Q. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-9 · Cited by 140
“Some of the many cellular processes regulated by PKCs include apoptosis, proliferation, migration, motility, chemo-resistance and differentiation (reviewed in [1-4]).”
Onco-Golgi: Is Fragmentation a Gate to Cancer Progression?
Petrosyan, A. (2015) · Biochemistry & Molecular Biology Journal · doi:10.21767/2471-8084.100006 · Cited by 138
The atypical PKCs in inflammation: NF‐κB and beyond
Diaz‐Meco, M. T., & Moscat, J. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01093.x · Cited by 131
“Increased DAG levels reversibly recruit cPKCs and nPKCs to the membrane through their zinc-finger (C1) domains (19).”
BackgroundTwo Faces of Protein Kinase Cδ: The Contrasting Roles of PKCδ in Cell Survival and Cell Death
Basu, A., & Pal, D. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.214 · Cited by 130
“It has been reported that activation of Akt by oncogenic Ras requires PKC activity[98].”
BackgroundInfluentialThe PKC/NF-κB Signaling Pathway Induces APOBEC3B Expression in Multiple Human Cancers
Leonard, B. C., McCann, J. L., Starrett, G. J., Kosyakovsky, L. B., Luengas, E. M., Molan, A. M., Burns, M. B., McDougle, R. M., Parker, P. J., Brown, W. L., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-2171-t · Cited by 145
The regulated assembly of a PKCɛ complex controls the completion of cytokinesis
Saurin, A. T., Durgan, J., Cameron, A. J. M., Faisal, A., Marber, M. S., & Parker, P. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1749 · Cited by 151
“Indeed, the three defining inputs (PKC, GSK3 and p38) have all previously been implicated in cance”
BackgroundProtein kinase C signaling and cell cycle regulation
Black, A. R., & Black, J. D. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00423 · Cited by 125
““fimmu-03-00423” — 2013/1/17 — 10:57 — page 1 — #1 REVIEW ARTICLE published: 17 January 2013 doi: 10.3389/fimmu.2012.00423 Protein kinase C signaling and cell cycle regulation”
BackgroundInfluentialWilliams, K. C., & Coppolino, M. G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.297069 · Cited by 125
Huang, J., Wu, S., Wu, C.-L., & Manning, B. D. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0975 · Cited by 123
Chen, J., Deng, F., Singh, S. V., & Wang, Q. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5156 · Cited by 133
“LNCaP cells were stained for PKD1 (1) or PKD2 (4); DU145 cells were stained for PKD3 (2) or PKD2 (5); PC3 cells were stained for PKD2 (6 ) and active PKD by p-S744/748-PKD antibody (3).”
BackgroundChiu, W., Shen, S., Chow, J., Lin, C., Shia, L.-T., & Chen, Y.-C. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.09.015 · Cited by 126
Aziz, M. H., Manoharan, H. T., Church, D. R., Dreckschmidt, N. E., Zhong, W., Oberley, T. D., Wilding, G., & Verma, A. K. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1604 · Cited by 124
Bessa, C., Soares, J., Raimundo, L., Loureiro, J. B., Gomes, C., Reis, F., Soares, M. L., Santos, D., Dureja, C., Chaudhuri, S. R., et al. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0154-9 · Cited by 123
Self-citationKasashima, H., Duran, A., Martinez-Ordoñez, A., Nakanishi, Y., Kinoshita, H., Linares, J. F., Reina-Campos, M., Kudo, Y., L’Hermitte, A., Yashiro, M., et al. (2021) · Developmental Cell · doi:10.1016/j.devcel.2020.10.014 · Cited by 118
Jubaidi, F. F., Zainalabidin, S., Taib, I. S., Hamid, Z. A., Anuar, N. N. M., Jalil, J., Nor, N. A. M., & Budin, S. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158582 · Cited by 130
“PKC is a family of isoforms that are subdivided into the classical PKCs (PKCα, PKCβ1, PKCβII, and PKCγ), novel PKCs (PKCδ, PKCε, PKCη, and PKCθ) and atypical PKCs (PKCζ and PKCι) [7].”
The plant non-specific phospholipase C gene family. Novel competitors in lipid signalling
Pokotylo, I., Pejchar, P., Potocký, M., Kocourková, D., Krčková, Z., Ruelland, É., Kravets, V. S., & Martinec, J. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2012.09.001 · Cited by 121
“Indeed, PKC is the principal target of DAG regulation in animal cells [167].”
BackgroundKulke, M. H., Freed, E., Chiang, D. Y., Philips, J., Zahrieh, D., Glickman, J. N., & Shivdasani, R. A. (2008) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20561 · Cited by 126
“Limited areas included the locus of OR4A5, a gene expressed in neuroendocrine cells of the brain and pancreas but not known to have oncogenic functions, and that for PRKCA, which is implicated in growth factor and hormonal signaling (Regnauld et al., 2002; Griner and Kazanietz, 2007 ).”
BackgroundMicroRNA-200b targets protein kinase Cα and suppresses triple-negative breast cancer metastasis
Humphries, B. A., Wang, Z., Oom, A. L., Fisher, T., Tan, D., Cui, Y., Jiang, Y., & Yang, C. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu133 · Cited by 113
“Protein kinase Cα (PKCα) is a member of PKC family of serine/ threonine kinases containing 10 isozymes, playing important roles in regulating cell migration and cancer metastasis (29,30).”
BackgroundDiacylglycerol kinases in immune cell function and self‐tolerance
Zhong, X., Guo, R., Zhou, H., Liu, C., & Wan, C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00647.x · Cited by 107
“The classic and novel types of protein kinases (PKCs), Ras guanyl nucleotide releasing proteins (RasGRPs), protein kinase Ds (PKDs), Munc-13s, a and b chimaerins, and the transient receptor potential cation channel (TRPC) are the most well-known DAG effector molecules (39).”
BackgroundSaba, J., Bonneil, E., Pomiès, C., Eng, K., & Thibault, P. (2009) · Journal of Proteome Research · doi:10.1021/pr801106a · Cited by 110
Exploitation of protein kinase C: A useful target for cancer therapy
Ali, A. S., Ali, S. S., El‐Rayes, B. F., Philip, P. A., & Sarkar, F. H. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.07.006 · Cited by 112
Protein kinase C as a tumor suppressor
Newton, A. C. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.04.017 · Cited by 105
“PKCδ, which has roles both in survival and apoptotic pathways [38,101], has been reported to promote tumor progression in pancreatic cancer [102], and mice deficient in this isozyme have an increased incidence of lung tumors [103].”
Punicic acid is an ω-5 fatty acid capable of inhibiting breast cancer proliferation
Cleary (2009) · International Journal of Oncology · doi:10.3892/ijo_00000515 · Cited by 98
Polyphenol compounds and PKC signaling
Das, J., Ramani, R., & Suraju, M. O. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.06.022 · Cited by 119
“Their balanced activity is essential for a healthy cell [57,94].”
Aziz, M. H., Hafeez, B. B., Sand, J. M., Pierce, D. B., Aziz, S. W., Dreckschmidt, N. E., & Verma, A. K. (2010) · Oncogene · doi:10.1038/onc.2010.63 · Cited by 103
Guzman, M. L., Li, X., Corbett, C. A., Rossi, R. M., Bushnell, T., Liesveld, J. L., Hébert, J., Young, F., & Jordan, C. T. (2007) · Blood · doi:10.1182/blood-2007-05-088815 · Cited by 107
Metadata
- Authors
- Griner, E. M., & Kazanietz, M. G.
- Affiliations
- University of Pennsylvania (US)
- Corresponding author
- Kazanietz, Marcelo G.
- Venue
- Nature Reviews Cancer
- Published
- 2007-04
- Volume
- 7
- Issue
- 4
- Pages
- 281-294
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1987496015
- Cited by
- 978
- References
- 190
- Citations by year
- 2026: 11 · 2025: 25 · 2024: 16 · 2023: 28 · 2022: 32 · 2021: 35 · 2020: 47 · 2019: 35 · 2018: 46 · 2017: 56 · 2016: 55 · 2015: 44 · 2014: 80 · 2013: 66 · 2012: 71
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- protein kinase C, diacylglycerol, phorbol ester, tumor promotion, carcinogenesis, tumor progression, cell cycle regulation, apoptosis, malignant transformation, cell survival, small GTPases, signal transduction
- MeSH terms
- Cell Cycle, Diglycerides, Enzyme Activation, Humans, Isoenzymes, Neoplasms, Neovascularization, Pathologic, Peptide Hydrolases, Phorbol Esters, Protein Kinase C, Apoptosis, GTP Phosphohydrolases, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.